HTGM
Htg Molecular Diagnostics, Inc
Glaxosmithkline Plc sold $3.0M of Htg Molecular Diagnostics, Inc
Former 10% Owner
Sold$3,045,180
$10.15Price
300,000Shares
−27%Stake
What HTGM did after the filing
Prices for HTGM after this filing aren't in yet.
Traded Mon, Mar 27. Filed Thu, Mar 30, 4:11 PM ET, after the close. Not investment advice.